Barbara Mullin is a Partner in the Firm's Litigation department, with a focus on patent litigation. Ms. Mullin has over 25 years of experience litigating patent infringement disputes. She regularly tries patent cases in federal courts and before arbitration panels and has argued before the Court of Appeals for the Federal Circuit. Her cases have involved diverse fields such as recombinant antibody technology, medical devices and methods, small molecule pharmaceuticals, semiconductor wafer processing, and water guns. In addition to representing clients in litigation and arbitration proceedings, Ms. Mullin also counsels innovator pharmaceutical and medical device clients on strategic patenting and licensing and freedom to operate issues, as well as Orange Book Listings, Paragraph IV certifications, and other ANDA-related matters. In November 2021, Ms. Mullin was selected as The American Lawyer’s ‘Litigator of the Week’ for securing a significant trial victory for a Fortune 100 pharmaceutical company.
Alternative Dispute Resolution | Biotechnology | Intellectual Property Litigation | Life Sciences / Health Care | Litigation | Patent Litigation
© Patterson Belknap Webb & Tyler LLP, 2022